Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Andrew Lewin

Andrew Lewin

Director, Business Development, Oxford Biomedica

Andy Lewin is part of the Business Development team at Oxford BioMedica with a specific interest in developing partnerships around their proprietary manufacturing platform and LentiVector technology. Andy has strong experience in the biologics manufacturing sector; before joining Oxford BioMedica, Andy has was Vice President Business Development at AGC Biologics, and headed Business Development at SynCo Bio Partners, Cobra Bio Manufacturing and at BioOutsource, where he was a cofounder.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd